The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
The Food and Drug Administration has again paused trials for Regenxbios gene therapy for a rare childhood brain disorder, after small masses were found on the spines of five patients, the company sai… [+699 chars]